BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,029 | +12.2% | 20,502 | +41.2% | 0.00% | 0.0% |
| Q2 2023 | $917 | +6953.8% | 14,524 | +4908.3% | 0.00% | – |
| Q1 2023 | $13 | -100.0% | 290 | -88.7% | 0.00% | – |
| Q1 2022 | $164,000 | +241.7% | 2,569 | +366.2% | 0.00% | – |
| Q3 2021 | $48,000 | 0.0% | 551 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | – | 551 | +8.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 508 | +408.0% | 0.00% | – |
| Q1 2020 | $5,000 | -96.9% | 100 | -95.5% | 0.00% | – |
| Q3 2019 | $161,000 | -43.3% | 2,198 | -51.0% | 0.00% | -100.0% |
| Q2 2018 | $284,000 | +195.8% | 4,484 | +249.2% | 0.00% | -75.0% |
| Q4 2017 | $96,000 | -41.5% | 1,284 | -68.7% | 0.00% | -42.9% |
| Q1 2017 | $164,000 | +1540.0% | 4,106 | +1009.7% | 0.01% | +600.0% |
| Q3 2016 | $10,000 | +900.0% | 370 | +386.8% | 0.00% | – |
| Q2 2016 | $1,000 | -96.3% | 76 | -92.6% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | +800.0% | 1,026 | +460.7% | 0.00% | – |
| Q3 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |